{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:23:58Z","timestamp":1781310238032,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bbrc.2021.01.089","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T07:54:45Z","timestamp":1615103685000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["TTK inhibitor promotes radiosensitivity of liver cancer cells through p21"],"prefix":"10.1016","volume":"550","author":[{"given":"Haibo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhou","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxian","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9479-0936","authenticated-orcid":false,"given":"Xiaodong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbrc.2021.01.089_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.bbrc.2021.01.089_bib2","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180109","article-title":"Leader of the SAC: molecular mechanisms of Mps1\/TTK regulation in mitosis","volume":"8","author":"Pachis","year":"2018","journal-title":"Open Biol."},{"issue":"7","key":"10.1016\/j.bbrc.2021.01.089_bib3","first-page":"E1570","article-title":"Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer","volume":"115","author":"Thu","year":"2018"},{"issue":"22","key":"10.1016\/j.bbrc.2021.01.089_bib4","doi-asserted-by":"crossref","first-page":"R966","DOI":"10.1016\/j.cub.2012.10.006","article-title":"The spindle assembly checkpoint","volume":"22","author":"Lara-Gonzalez","year":"2012","journal-title":"Curr. Biol. : CB"},{"key":"10.1016\/j.bbrc.2021.01.089_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopha.2016.08.004","article-title":"HLF\/miR-132\/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells","volume":"83","author":"Chen","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"15","key":"10.1016\/j.bbrc.2021.01.089_bib6","first-page":"1871","article-title":"Targeting the cell cycle in breast cancer: towards the next phase","volume":"17","author":"Thu","year":"2018"},{"issue":"4","key":"10.1016\/j.bbrc.2021.01.089_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174863","article-title":"Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability","volume":"12","author":"Stratford","year":"2017","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.bbrc.2021.01.089_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097739","article-title":"Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for human hepatocellular carcinoma","volume":"9","author":"Liang","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bbrc.2021.01.089_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2014.05.025","article-title":"Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis","volume":"61","author":"Miao","year":"2014","journal-title":"J.\u00a0Hepatol."},{"issue":"33","key":"10.1016\/j.bbrc.2021.01.089_bib10","doi-asserted-by":"crossref","first-page":"34309","DOI":"10.18632\/oncotarget.5295","article-title":"TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbrc.2021.01.089_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1083\/jcb.201002133","article-title":"Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex","volume":"190","author":"Hewitt","year":"2010","journal-title":"J.\u00a0Cell Biol."},{"issue":"6","key":"10.1016\/j.bbrc.2021.01.089_bib12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1667\/RR14951.1","article-title":"In\u00a0vitro radiobiological advantages of hypofractionation compared with conventional fractionation: early-passage NSCLC cells are less aggressive after hypofractionation","volume":"190","author":"Zhang","year":"2018","journal-title":"Radiat. Res."},{"issue":"2","key":"10.1016\/j.bbrc.2021.01.089_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.radonc.2012.04.021","article-title":"G2 checkpoint abrogator abates the antagonistic interaction between antimicrotubule drugs and radiation therapy","volume":"104","author":"Sui","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.bbrc.2021.01.089_bib14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/1541-7786.MCR-14-0462-T","article-title":"Targeting MPS1 enhances radiosensitization of human glioblastoma by modulating DNA repair proteins","volume":"13","author":"Maachani","year":"2015","journal-title":"Mol. Canc. Res. : MCR"},{"key":"10.1016\/j.bbrc.2021.01.089_bib15","volume":"vol. 6","author":"Ji","year":"2017"},{"issue":"6","key":"10.1016\/j.bbrc.2021.01.089_bib16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cub.2018.02.002","article-title":"Mps1 phosphorylates its N-terminal extension to relieve autoinhibition and activate the spindle assembly checkpoint","volume":"28","author":"Combes","year":"2018","journal-title":"Curr. Biol. : CB"},{"issue":"12","key":"10.1016\/j.bbrc.2021.01.089_bib17","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41416-018-0081-2","article-title":"Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division","volume":"118","author":"Maia","year":"2018","journal-title":"Br. J. Canc."},{"issue":"46","key":"10.1016\/j.bbrc.2021.01.089_bib18","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1038\/onc.2017.266","article-title":"Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma","volume":"36","author":"Szymiczek","year":"2017","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bbrc.2021.01.089_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005849","article-title":"Cell cycle time series gene expression data encoded as cyclic attractors in Hopfield systems","volume":"13","author":"Szedlak","year":"2017","journal-title":"PLoS Comput. Biol."},{"issue":"8","key":"10.1016\/j.bbrc.2021.01.089_bib20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/cancers11081178","article-title":"p21 in cancer research","volume":"11","author":"Shamloo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2021.01.089_bib21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2021.01.089_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature07618","article-title":"Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells","volume":"457","author":"Viale","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2021.01.089_bib23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ncb3382","article-title":"p21 shapes cancer evolution","volume":"18","author":"Romanov","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.01.089_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","article-title":"Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage","volume":"42","author":"Karimian","year":"2016","journal-title":"DNA Repair"},{"issue":"3","key":"10.1016\/j.bbrc.2021.01.089_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tibs.2013.12.007","article-title":"Selenium andselenocysteine: roles in cancer, health, and development","volume":"39","author":"Hatfield","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2021.01.089_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/nar\/gkv927","article-title":"The p53-p21-DREAM-CDE\/CHR pathway regulates G2\/M cell cycle genes","volume":"44","author":"Fischer","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bbrc.2021.01.089_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.dnarep.2009.12.003","article-title":"PCNA-coupled p21 degradation after DNA damage:the exception that confirms the rule?","volume":"9","author":"Soria","year":"2010","journal-title":"DNA Repair"}],"updated-by":[{"DOI":"10.1016\/j.bbrc.2021.03.164","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000}}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T03:27:33Z","timestamp":1671679653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"alternative-id":["S0006291X21001546"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.089","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bbrc.2021.03.164","asserted-by":"object"}]},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TTK inhibitor promotes radiosensitivity of liver cancer cells through p21","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}